<DOC>
	<DOCNO>NCT02504125</DOCNO>
	<brief_summary>A randomized , double-blind , single-center control study compare efficacy safety intravenous administration tranexamic acid reduce blood loss simultaneous bilateral total knee arthroplasty .</brief_summary>
	<brief_title>The Efficacy Safety Using Tranexamic Acid Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty</brief_title>
	<detailed_description>A randomized , double-blind , single-center control study compare efficacy safety intravenous administration tranexamic acid reduce blood loss simultaneous bilateral total knee arthroplasty . Subjects monitor occurrence complication , particularly deep venous thrombosis thromboembolism hospital stay 1 month postoperatively .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Adult patient plan undergo simultaneous primary total knee arthroplasty bilateral knee joint diagnosis osteoarthritis aseptic bone necrosis , rheumatoid arthritis ; All patient normal preoperative platelet count , normal prothrombin time , normal partial thromboplastin time , normal international normalized ratio ; The use balance electrolyte solution and/or albumin plasma volume restitution Allergy tranexamic acid ; Receiving warfarin heparin ; history hemophilia , deep venous thrombosis , pulmonary embolism , renal impairment ; pregnant ; Patients cardiovascular problem ( myocardiac infarction history , atrial fibrillation , angina ) ; Patients thromboembolic disorder , exhibit deteriorate general condition ; Preoperative anemia ( hemoglobin value &lt; 11 g/dL female &lt; 12 g/dL male ) , refusal blood product ; Preoperative use anticoagulant therapy within five day surgery , fibrinolytic disorder require intraoperative antifibrinolytic treatment , coagulopathy ( identify preoperative platelet count &lt; 150,000/mm3 , international normalize ratio &gt; 1.4 , prolong partial thromboplastin time [ &gt; 1.4 time normal ] ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>